Biogen to Present Clinical Data from Neurology Portfolio at AAN Annual Meeting
April 14, 2014 at 07:31 AM EDT
- Two-Year Data from Pivotal Phase 3 ADVANCE Study for PLEGRIDY™ (Peginterferon Beta-1a) to Be Presented - - New TECFIDERA® ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.